Drug Eruption and Interactions - PHARMACEUTICAL REVIEW
Share Embed Flag
Download ePaper

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

(1980): Couzigou P+, Therapie 35(3), 403 Myalgia/Myositis/Myopathy/Myotoxicity (2007): Dedhia V+, J Assoc Physicians India (India) 55, 152 (with rosuvastatin) (2006): Lukjanowicz M+, Pol Arch Med Wewn 115(1), 45 (2005): Litt JZ, Beachwood, OH (personal case) (observation) (2004): Ghosh B+, Neurol India 52(2), 268 (2002): Najib J, Clin Ther 24(12), 2022 (2001): Rabasa-Lhoret R+, Diabetes Metab 27(1), 66 (1993): Berger O+, Nervenarzt 64(8), 539 (1991): Solsona L+, Med Clin (Barc) (Spanish) 97, 677 (1989): Am J Med 83, 26 (1%) (1989): Muller JP+, Presse Med 18(20), 1033 (1982): Giraud P+, Rev Rhum Mal 49(2), 162 Rhabdomyolysis (2006): Archambeaud-Mouveroux F+, Rev Med Interne 27(7), 573 (2005): Ireland JH+, AnnInternMed142(11), 949 (with rosuvastatin) (2005): Jones PH+, Am J Cardiol 95(1), 120 (with statins) (2005): Kursat S+, Clin Nephrol 64(5), 391 (with statins) (2003): Barker BJ+, Diabetes Care 26(8), 2482 (2000): Duda-Krol W+, Wiad Lek 53(7), 454 (1999): Clouatre Y+, NephrolDialTransplant14(4), 1047 (1993): Berger O+, Nervenarzt 64(8), 539 (1992): Raimondeau J+, Presse Med 21(14), 663 (with pravastatin) Septic–toxic shock (2000): Duda-Krol W+, Wiad Lek 53(7), 454 FENOLDOPAM Trade name: Corlopam (Abbott) (Neurex) Indications: Hypertension (severe), hypertensive emergency Category: Dopamine receptor agonist Half-life: ~5 minutes Clinically important, potentially hazardous interactions with: None Skin Diaphoresis Other Injection-site reactions FENOPROFEN Reactions Trade names: Fenoprex; Fenopron; Fepron; Feprona; Nalfon (Ranbaxy); Nalgesic; Progesic Indications: Arthritis Category: Non-steroidal anti-inflammatory Half-life: 2.5–3 hours Clinically important, potentially hazardous interactions with: methotrexate Skin Acne Angioedema (

224 FENTANYL Exfoliative dermatitis Fixed eruption (2001): Vaughan K, Lakewood, WA (from patch) (from Internet) (observation) Papulo-nodular lesions (>1%) Pruritus (3–44%) (2006): Sarvela PJ+, Acta Anaesthesiol Scand 50(2), 239 (2002): Gurkan Y+, Anesth Analg 95(6), 1763 (2002): Henry A+, RegAnesthPainMed27(5), 538 (intrathecal) (2002): Nelson KE+, Anesthesiology 96(5), 1070 (1999): Herman NL+, Anesth Analg 89, 378 (1996): Larijani GE+, Pharmacotherapy 16, 958 (1994): Gerwels JW+, JDermatolSurgOncol20, 823 (1992): Badner NH+, Can J Anaesth 39, 330 (1992): Belzarena SD, Anesth Analg 74, 653 (1992): Calis KA+, Clin Pharm 11, 22 (1992): Friesen RH+, Anesthesiology 76, 46 (facial) (1992): Mosser KH, Am Fam Physician 45, 2289 (1992): Mourisse J+, Acta Anaesthesiol Scand 36, 70 (1992): Paech MJ, Anaesth Intensive Care 20, 15 (1992): Sandler ES+, Pediatrics 89, 631 (1992): Varrassi G+, Anaesthesia 47, 558 (1992): White MJ+, Can J Anaesth 39, 594 (1989): Ackerman WE+, Can J Anaesth 36, 388 (1989): Jorrot JC+, AnnFrAnesthRéanim(French) 8, 321 (22%) (1988): Davies GG+, Anesthesiology 69, 763 (1988): Monk JP+, Drugs 36, 286 (40%) (1986): Shipton EA+, SAfrMedJ70, 325 (13%) Purpura (2001): Tweed WA+, Anesth Analg 92, 1442 Pustules (1%) (1992): Sandler ES+, Pediatrics 89, 631 (1992): Stoukides CA+, Clin Pharm 11, 222 Urticaria (10%) (2001): Litt JZ, Beachwood, OH (personal case) (observation) (1992): Calis KA+, Clin Pharm 11, 22 Other Anaphylactoid reactions/Anaphylaxis (2007): Cummings KC 3rd+, Can J Anaesth 54(4), 301 (2001): Girgis Y, Anaesthesia 56(10), 1016 (2001): Konarzewski W+, Anaesthesia 56(5), 497 (with propofol) (fatal) (2001): Lewis S+, Anaesthesia 56(11), 1128 (1990): Ducker P+, ZHautkr(German) 65, 734 Cough (2007): Yeh CC+, J Clin Anesth 19(1), 53 (2006): Oshima T+, Can J Anaesth 53(8), 753 (2005): Schlimp CJ+, Can J Anaesth 52(2), 207 (2004): Pandey CK+, Anesth Analg 99(6), 1696 (2002): Tsou CH+, Acta Anaesthesiol Sin 40(4), 165 (2001): Tweed WA+, Anesth Analg 92(6), 1442 Death (2005): Ekedahl A+, Lakartidningen 102(39), 2788 (2002): Mertes PM+, Anaesthesia 57(8), 821 (with propofol) (2002): Reeves MD+, Med J Aust 177(10), 552 (2001): Girgis Y, Anaesthesia 56(10), 1016 Inappropriate secretion of antidiuretic hormone (SIADH) (2002): Kokko H+, Pharmacotherapy 22(9), 1188 FEVERFEW Scientific names: Chrysanthemum parthenium; Pyrethrum parthenium; Tanacetum parthenium Family: Asteraceae; Compositae Trade and other common names: Atamisa; Featerfoiul; Featherfew; Featherfoil; MIG-99; Santa Maria Category: Antipyretic Purported indications and other uses: Fever, headache, migraine, menstrual irregularities, arthritis, psoriasis, allergy, asthma, tinnitus, vertigo, nausea, cold, earache, orthopedic disorders, swollen feet, diarrhea, dyspepsia Half-life: N/A Clinically important, potentially hazardous interactions with: anticoagulants, NSAIDs, warfarin Reactions Skin Adverse effects (sic) (mild) (2000): Ernst E+, Public Health Nutr 3(4A), 509 Allergic reactions (sic) (1983): Hausen BM+, Acta Derm Venereol 63(4), 308 Angioedema (lips) (1998): Awang DVC, Int Med 1, 11 (1985): Johnson ES+, BMJ (Clin Res Ed) 291, 569 Dermatitis (2006): Verma KK+, Indian J Dermatol Venereol Leprol 72(1), 24 (2002): Paulsen E+, Contact Dermatitis 47(1), 14 (1996): Lamminpaa A+, Contact Dermatitis 34, 330 Prurigo nodularis (2000): Sharma VK+, Contact Dermatitis 42(4), 235 Mucosal Oral ulceration (1998): Awang DVC, Int Med 1, 11 (1985): Johnson ES+, BMJ (Clin Res Ed) 291, 569 FEXOFENADINE Trade name: Allegra (Sanofi-Aventis) Indications: Allergic rhinitis, pruritus, urticaria Category: Histamine H1 receptor antagonist Half-life: 14.4 hours Clinically important, potentially hazardous interactions with: St John’s wort Reactions Skin Acne (1998): Litt JZ, Beachwood, OH (personal case) (observation) Psoriasis (2006): Saraswat A+, Clin Exp Dermatol 31(3), 477 (Pustular) Pustules (2006): Saraswat A+, Clin Exp Dermatol 31(3), 477 FILGRASTIM (See GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF))

(1980): Couzigou P+, Therapie 35(3), 403<br />

Myalgia/Myositis/Myopathy/Myotoxicity<br />

(2007): Dedhia V+, J Assoc Physicians India (India) 55, 152 (with<br />

rosuvastatin)<br />

(2006): Lukjanowicz M+, Pol Arch Med Wewn 115(1), 45<br />

(2005): Litt JZ, Beachwood, OH (personal case) (observation)<br />

(2004): Ghosh B+, Neurol India 52(2), 268<br />

(2002): Najib J, Clin Ther 24(12), 2022<br />

(2001): Rabasa-Lhoret R+, Diabetes Metab 27(1), 66<br />

(1993): Berger O+, Nervenarzt 64(8), 539<br />

(1991): Solsona L+, Med Clin (Barc) (Spanish) 97, 677<br />

(1989): Am J Med 83, 26 (1%)<br />

(1989): Muller JP+, Presse Med 18(20), 1033<br />

(1982): Giraud P+, Rev Rhum Mal 49(2), 162<br />

Rhabdomyolysis<br />

(2006): Archambeaud-Mouveroux F+, Rev Med Interne<br />

27(7), 573<br />

(2005): Irel<strong>and</strong> JH+, AnnInternMed142(11), 949 (with<br />

rosuvastatin)<br />

(2005): Jones PH+, Am J Cardiol 95(1), 120 (with statins)<br />

(2005): Kursat S+, Clin Nephrol 64(5), 391 (with statins)<br />

(2003): Barker BJ+, Diabetes Care 26(8), 2482<br />

(2000): Duda-Krol W+, Wiad Lek 53(7), 454<br />

(1999): Clouatre Y+, NephrolDialTransplant14(4), 1047<br />

(1993): Berger O+, Nervenarzt 64(8), 539<br />

(1992): Raimondeau J+, Presse Med 21(14), 663 (with<br />

pravastatin)<br />

Septic–toxic shock<br />

(2000): Duda-Krol W+, Wiad Lek 53(7), 454<br />

FENOLDOPAM<br />

Trade name: Corlopam (Abbott) (Neurex)<br />

Indications: Hypertension (severe), hypertensive emergency<br />

Category: Dopamine receptor agonist<br />

Half-life: ~5 minutes<br />

Clinically important, potentially hazardous interactions<br />

with: None<br />

Skin<br />

Diaphoresis<br />

Other<br />

Injection-site reactions<br />

FENOPROFEN<br />

Reactions<br />

Trade names: Fenoprex; Fenopron; Fepron; Feprona; Nalfon<br />

(Ranbaxy); Nalgesic; Progesic<br />

Indications: Arthritis<br />

Category: Non-steroidal anti-inflammatory<br />

Half-life: 2.5–3 hours<br />

Clinically important, potentially hazardous interactions<br />

with: methotrexate<br />

Skin<br />

Acne<br />

Angioedema (

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!